{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T07:05:40Z","timestamp":1763017540542},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1093\/ageing\/afv065","type":"journal-article","created":{"date-parts":[[2015,5,27]],"date-time":"2015-05-27T00:00:30Z","timestamp":1432684830000},"page":"566-573","source":"Crossref","is-referenced-by-count":16,"title":["Antidiabetic and cardiovascular drug utilisation in patients diagnosed with type 2 diabetes mellitus over the age of 80 years: a population-based cohort study"],"prefix":"10.1093","volume":"44","author":[{"given":"Shota","family":"Hamada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin C.","family":"Gulliford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2015,5,25]]},"reference":[{"key":"key\n\t\t\t\t20170506041149_AFV065C1","article-title":"Prescribing for Diabetes. England 2005\u201306 to 2013\u201314","author":"Health and Social Care Information Centre","year":"2014"},{"key":"key\n\t\t\t\t20170506041149_AFV065C2","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","article-title":"10-Year follow-up of intensive glucose control in type 2 diabetes","volume":"359","year":"2008","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170506041149_AFV065C3","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1161\/CIRCULATIONAHA.108.829176","article-title":"Trends in all-cause and cardiovascular disease mortality among women and men with and without diabetes mellitus in the Framingham Heart Study, 1950 to 2005","volume":"119","year":"2009","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20170506041149_AFV065C4","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1056\/NEJMoa0706245","article-title":"Effect of a multifactorial intervention on mortality in type 2 diabetes","volume":"358","year":"2008","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170506041149_AFV065C5","article-title":"Type 2 Diabetes","author":"National Institute for Health and Care Excellence","year":"2014"},{"key":"key\n\t\t\t\t20170506041149_AFV065C6","article-title":"The Ageing Population","year":"2010"},{"key":"key\n\t\t\t\t20170506041149_AFV065C7","article-title":"National Diabetes Audit \u2013 2011\u201312","author":"Health and Social Care Information Centre","year":"2013"},{"key":"key\n\t\t\t\t20170506041149_AFV065C8","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/jgs.12215","article-title":"Exclusion of older adults from ongoing clinical trials about type 2 diabetes mellitus","volume":"61","year":"2013","journal-title":"J Am Geriatr Soc"},{"key":"key\n\t\t\t\t20170506041149_AFV065C9","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1111\/jgs.12513","article-title":"Management of cardiovascular disease risk factors in older adults with type 2 diabetes mellitus: 2002\u20132012 literature review","volume":"61","year":"2013","journal-title":"J Am Geriatr Soc"},{"key":"key\n\t\t\t\t20170506041149_AFV065C10","first-page":"877","article-title":"VIII. Study design, progress and performance","volume":"34","author":"UK Prospective Diabetes Study (UKPDS)","year":"1991","journal-title":"Diabetologia"},{"key":"key\n\t\t\t\t20170506041149_AFV065C11","doi-asserted-by":"crossref","first-page":"21i","DOI":"10.1016\/j.amjcard.2007.03.003","article-title":"Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: design and methods","volume":"99","author":"ACCORD Study Group","year":"2007","journal-title":"Am J Cardiol"},{"key":"key\n\t\t\t\t20170506041149_AFV065C12","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1002\/pds.1802","article-title":"Trends in the prescription of antidiabetic medications in the United Kingdom: a population-based analysis","volume":"18","year":"2009","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"key\n\t\t\t\t20170506041149_AFV065C13","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1111\/j.1365-2125.2012.04401.x","article-title":"Prescribing pattern of glucose lowering drugs in the United Kingdom in the last decade: a focus on the effects of safety warnings about rosiglitazone","volume":"75","year":"2013","journal-title":"Br J Clin Pharmacol"},{"key":"key\n\t\t\t\t20170506041149_AFV065C14","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/sj.jhh.1001787","article-title":"Trends in antihypertensive and lipid-lowering therapy in subjects with type II diabetes: clinical effectiveness or clinical discretion?","volume":"19","year":"2005","journal-title":"J Hum Hypertens"},{"key":"key\n\t\t\t\t20170506041149_AFV065C15","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.puhe.2006.03.010","article-title":"Management of cardiovascular risk factors in people with diabetes in primary care: cross-sectional study","volume":"120","year":"2006","journal-title":"Public Health"},{"key":"key\n\t\t\t\t20170506041149_AFV065C16","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.2337\/dc12-1801","article-title":"Diabetes in older adults","volume":"35","year":"2012","journal-title":"Diabetes Care"},{"key":"key\n\t\t\t\t20170506041149_AFV065C17","article-title":"Annual Report Jan 2013\u2013Dec 2013","author":"Independent Scientific Advisory Committee for MHRA database research (ISAC)"},{"key":"key\n\t\t\t\t20170506041149_AFV065C18","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1365-2125.2009.03537.x","article-title":"Validation and validity of diagnoses in the General Practice Research Database: a systematic review","volume":"69","year":"2010","journal-title":"Br J Clin Pharmacol"},{"key":"key\n\t\t\t\t20170506041149_AFV065C19","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","article-title":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)","volume":"352","author":"UK Prospective Diabetes Study (UKPDS) Group","year":"1998","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170506041149_AFV065C20","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/dom.12260","article-title":"How many people inject insulin? UK estimates from 1991 to 2010","volume":"16","year":"2014","journal-title":"Diabetes Obes Metab"},{"key":"key\n\t\t\t\t20170506041149_AFV065C21","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S0140-6736(98)07037-8","article-title":"Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)","volume":"352","author":"UK Prospective Diabetes Study (UKPDS) Group","year":"1998","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170506041149_AFV065C22","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.2337\/dc14-1306","article-title":"Sulfonylurea use and incident cardiovascular disease among patients with type 2 diabetes: prospective cohort study among women","volume":"37","year":"2014","journal-title":"Diabetes Care"},{"key":"key\n\t\t\t\t20170506041149_AFV065C23","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1136\/bmj.317.7160.713","article-title":"Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39","volume":"317","author":"UK Prospective Diabetes Study Group","year":"1998","journal-title":"BMJ"},{"key":"key\n\t\t\t\t20170506041149_AFV065C24","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1093\/eurheartj\/ehs092","article-title":"European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts)","volume":"33","year":"2012","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20170506041149_AFV065C25","first-page":"1383","article-title":"Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)","volume":"344","author":"Scandinavian Simvastatin Survival Study Group","year":"1994","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170506041149_AFV065C26","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(02)09327-3","article-title":"MRC\/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial","volume":"360","author":"Heart Protection Study Collaborative Group","year":"2002","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170506041149_AFV065C27","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/bmj.308.6921.81","article-title":"Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients","volume":"308","author":"Antiplatelet Trialists\u2019 Collaboration","year":"1994","journal-title":"BMJ"},{"key":"key\n\t\t\t\t20170506041149_AFV065C28","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1001\/jama.2014.15690","article-title":"Low-dose aspirin for primary prevention of cardiovascular events in Japanese patients 60 years or older with atherosclerotic risk factors: a randomized clinical trial","volume":"312","year":"2014","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20170506041149_AFV065C29","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/jep.12104","article-title":"Near equality in quality for medication utilization among older adults with diabetes with universal medication insurance in Ontario, Canada","volume":"20","year":"2014","journal-title":"J Eval Clin Pract"},{"key":"key\n\t\t\t\t20170506041149_AFV065C30","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1007\/s00228-014-1678-x","article-title":"Changes in prescribing patterns and clinical outcomes in elderly diabetic patients in 2000 and 2010: analysis of a large Italian population-based study","volume":"70","year":"2014","journal-title":"Eur J Clin Pharmacol"}],"container-title":["Age and Ageing"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ageing\/article-pdf\/44\/4\/566\/16647989\/afv065.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,25]],"date-time":"2019-08-25T16:11:29Z","timestamp":1566749489000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ageing\/article-lookup\/doi\/10.1093\/ageing\/afv065"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,25]]},"references-count":30,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2015,5,25]]},"published-print":{"date-parts":[[2015,7]]}},"URL":"https:\/\/doi.org\/10.1093\/ageing\/afv065","relation":{},"ISSN":["1468-2834","0002-0729"],"issn-type":[{"value":"1468-2834","type":"electronic"},{"value":"0002-0729","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5,25]]}}}